Evidence map›Paper›PMID 16819576›Full record

ReviewHeart failure reviews2006

The nerve-heart connection in the pro-oxidant response to Mg-deficiency.

Maria Isabel Tejero-Taldo, Jay Harlan Kramer, Iu Tong Mak, Andrei M Komarov, William Bernard Weglicki

Abstract readReview
PubMed Publisher
In one paragraph

Review in Heart failure reviews, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 52 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. The NO/ONOO-cycle as the central cause of heart failure.International journal of molecular sciences · 2013
    Review
  16. Article
  17. Neurogenic inflammation and cardiac dysfunction due to hypomagnesemia.The American journal of the medical sciences · 2009
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Maria Isabel Tejero-TaldoDept. of Biochemistry & Molecular Biology, Div. of Experimental Medicine, The George Washington University Medical Center, Washington, DC 20037, USA. phymit@gwumc.edu
Jay Harlan Kramer
Iu Tong Mak
Andrei M Komarov
William Bernard Weglicki
University of Washington · US

Funding

Cardiomyopathy:Pro-Oxidant Role of Zidovudine (AZT)R01HL065178 · NHLBI · GEORGE WASHINGTON UNIVERSITY · PI WEGLICKI, WILLIAM BERNARD · 2000 to 2007
$2.7M
SUBSTANCE P-MEDIATED CARDIOVASCULAR INFLAMMATIONR01HL062282 · NHLBI · GEORGE WASHINGTON UNIVERSITY · PI WEGLICKI, WILLIAM BERNARD · 2000 to 2007
$2.5M
Substance P-mediated Cardiovascular InflammationR56HL062282 · NHLBI · GEORGE WASHINGTON UNIVERSITY · PI WEGLICKI, WILLIAM BERNARD · 2009 to 2009
$391k
NHLBI NIH HHS HL-62282NHLBI NIH HHS HL-65178
6 · The paper itself

Abstract

Magnesium is a micronutrient essential for the normal functioning of the cardiovascular system, and Mg deficiency (MgD) is frequently associated in the clinical setting with chronic pathologies such as CHF, diabetes, hypertension, and other pathologies. Animal models of MgD have demonstrated a systemic pro-inflammatory/pro-oxidant state, involving multiple tissues/organs including neuronal, hematopoietic, cardiovascular, and gastrointestinal systems; during later stages of MgD, a cardiomyopathy develops which may result from a cascade of inflammatory events. In rodent models of dietary MgD, a significant rise in circulating levels of proinflammatory neuropeptides such as substance P (SP) and calcitonin gene-related peptide among others, was observed within days (1-7) of initiating the Mg-restricted diet, and implicated a neurogenic trigger for the subsequent inflammatory events; this early "neurogenic inflammation" phase may be mediated in part, by the Mg-gated N: -methyl-D-aspartate (NMDA) receptor/channel complex. Deregulation of the NMDA receptor may trigger the abrupt release of neuronal SP from the sensory-motor C-fibers to promote the subsequent pro-inflammatory changes: elevations in circulating inflammatory cells, inflammatory cytokines, histamine, and PGE(2) levels, as well as formation of nitric oxide, reactive oxygen species, lipid peroxidation products, and depletion of key endogenous antioxidants. Concurrent elevations of tissue CD14, a high affinity receptor for lipopolyssacharide, suggest that intestinal permeability may be compromised leading to endotoxemia. If exposure to these early (1-3 weeks MgD) inflammatory/pro-oxidant events becomes prolonged, this might lead to impaired cardiac function, and when co-existing with other pathologies, may enhance the risk of developing chronic heart failure.

Indexed as

AnimalsAntioxidantsHeart FailureHumansInflammationMagnesium DeficiencyMyocardiumNeurokinin-1 Receptor AntagonistsNeuronsNitric OxideOxidative StressReceptors, N-Methyl-D-AspartateSubstance PAntioxidantsNeurokinin-1 Receptor AntagonistsNitric OxideReceptors, N-Methyl-D-AspartateSubstance P

Identifiers

PMID16819576
OpenAlexW2075368992

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.